KV Pharmaceutical Launches Enhanced Formulation of PrimaC... ( Sets New Standard for Prescription Pr...)

KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R)

Date:12/17/2008

Sets New Standard for Prescription Prenatal Vitamins

PrimaCare ONE(R) enhanced formulation now is the most comprehensive once-daily prescription prenatal vitamin in its category, delivering the most omega-3s, DHA and EPA

ST. LOUIS, Dec. 17 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) announced today that its Ther-Rx Corporation branded pharmaceutical subsidiary - the U.S. market leader in branded prenatal vitamins - has enhanced the formulation of one of its most innovative products, PrimaCare ONE(R). The enhanced PrimaCare ONE(R) replaces the previous formulation, immediately becoming the most comprehensive one-capsule-per day omega-3 prescription prenatal vitamin in the market and providing unmatched prenatal and postnatal nutritional support for mothers and babies.

The new enhanced formulation of PrimaCare ONE(R) now delivers the most omega-3s, and includes both DHA (Docosahexaenoic acid)and EPA (Eicosapentaenoic acid), along with 13 vitamins and minerals, folic acid, plus a stool softener. PrimaCare ONE(R) provides all of these benefits with the convenience of one-capsule-per day. The product demonstrates Ther-Rx's continued leadership in marketing innovative branded pharmaceuticals to women in their childbearing years as part of its PreCare(R) family prescription nutritional product line.

"Ther-Rx is committed to continuously enhancing our products based on both doctor and patient feedback," stated Greg Divis, President of Ther-Rx Corporation. "PrimaCare ONE(R) has been a tremendously successful contributor to our prenatal line. We are very excited to have the opportunity to further improve PrimaCare ONE(R) through this new enhanced formulation. We are now providing the most omega-3s in a one-capsule-per day product to help Mom's replace the up to 50% of essential fatty acid stores lost during pregnancy. The National
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures
2. MonoSol Rx Enters Agreement with Hikma Pharmaceuticals PLC for Thin Film Pharmaceutical Products in the Middle East
3. Daniel J. Nevrivy, Ph.D., Biotech and Pharmaceutical Patent Attorney, Launches New Law Firm Aimed at Helping Clients Preserve Their Capital
4. Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement
5. Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US
6. Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
7. Bi-Coastal Pharmaceutical Corp. Acquires U.S. Marketing Rights to Aquoral(TM) Artificial Saliva Product
8. Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities
9. Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
10. Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt
11. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009

Post Your Comments:

KV Pharmaceutical Launches Enhanced Formulation of PrimaC...( Sets New Standard for Prescription Pr...),Health